Active ingredient
Alcaftadine
5 finished FDA listings contain Alcaftadine as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- ALCAFTADINE
- Dosage forms
- Solution/ Drops
- Routes
- Ophthalmic
- Manufacturers / labelers
- 4
- Strengths listed
- 2.5 mg/ml
- Brand names in FDA listings
- Lastacaft
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1000082
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 022134 | ABBVIE | 2010-07-28 | 2 |
| ANDA 210659 | EUGIA PHARMA | 2023-06-23 | 1 |
| ANDA 209706 | GLAND | 2024-03-01 | 1 |
| ANDA 209290 | ALEMBIC | 2024-10-02 | 1 |
Official labeling on DailyMed
- LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [ALLERGAN, INC.] · version 21 · 2025-09-25
- LASTACAFT (ALCAFTADINE) SOLUTION/ DROPS [ALLERGAN, INC.] · version 4 · 2025-02-17
- ALCAFTADINE SOLUTION/ DROPS [ALEMBIC PHARMACEUTICALS INC.] · version 3 · 2024-10-09
- ALCAFTADINE SOLUTION/ DROPS [GLAND PHARMA LIMITED] · version 3 · 2024-03-07
- ALCAFTADINE SOLUTION/ DROPS [AUROHEALTH LLC] · version 1 · 2023-06-28
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.